Pediatric patients with cystic fibrosis starting triple combination therapy had larger relative improvements in 129Xenon MRI vs. lung function measures, according to data published in Annals of the ...
New research out of the University of Iowa is reshaping what it means to live with cystic fibrosis, a genetic disease that ...
From 2008 to 2023, there has been a significant decrease in cystic fibrosis mortality rates and a significant rise in sickle ...
Dose-ranging trial evaluated deupirfenidone 550 mg three times a day (TID) (approximately equivalent exposure to pirfenidone 801 mg TID 1) and deupirfenidone 825 mg TID and successfully demonstrated ...
Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting another 10%. Digestive conditions like GERD, acid reflux, Celiac disease ...
A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...
The Company continues working with the third-party manufacturer to address recent FDA follow-up information requests which are required to lift ...
Findings showed treatment with nerandomilast led to a significant improvement in lung function compared with placebo. Topline data were announced from a phase 3 trial evaluating nerandomilast, an oral ...
Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback